Alverta Lopez

Alverta Lopez supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health preparedness and scientific response. She manages complex acquisitions for laboratory diagnostics, biomedical research tools, and data infrastructure essential to disease surveillance and outbreak response. Her work ensures the timely procurement of high-precision analytical instruments, in-vitro diagnostic substances, and technical consulting services that underpin CDC’s operational readiness. She operates within a high-stakes environment where procurement decisions directly impact national health security, requiring rigorous compliance with federal acquisition regulations and alignment with scientific priorities. Lopez maintains consistent procurement relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Cepheid, GlaxoSmithKline, New York City Health & Hospitals Corp, and MRIGLOBAL. These partnerships reflect a focus on established vendors with proven capabilities in diagnostic testing, laboratory automation, biomedical supply chain management, and epidemiological data systems. Her contracting approach emphasizes reliability, regulatory compliance, and technical scalability, favoring vendors with demonstrated expertise in federal health programs and validated quality management systems. Lopez’s procurement portfolio reflects a strong preference for full and open competition, with 100% of awards issued under no set-aside classifications. This underscores a strategic emphasis on accessing the broadest possible pool of technical expertise and industrial capacity, prioritizing mission effectiveness over socioeconomic set-asides. While small business participation is not formally targeted through set-asides, her contracting actions remain compliant with all applicable small business goals and may include small business subcontracting as part of larger prime contracts. Her primary procurement focus lies in NAICS 334516 (analytical laboratory instrumentation), 325413 (in-vitro diagnostic manufacturing), and 541380 (testing laboratories), with significant activity in 541690 (scientific consulting) and 423490 (professional equipment wholesale). She specializes in acquiring high-complexity diagnostic systems, reagent kits, clinical data platforms, and laboratory support services critical to infectious disease detection and public health surveillance infrastructure.